What does pulmonary hypertension patient often eat good?

summary

Many patients with pulmonary hypertension are not familiar with this disease, because it is a rare disease. Patients who have just suffered from pulmonary hypertension will be more concerned about how to treat this disease and what to eat. Patients with pulmonary hypertension need to choose the treatment method suitable for their own condition, improve the quality of life of patients and prolong their life. Let's talk about what patients with pulmonary hypertension often eat?.

What does pulmonary hypertension patient often eat good?

First: calcium antagonists: nifedipine and diltiazem are commonly used calcium antagonists (CCB). Nifedipine was used when the heart rate was slow, and diltiazem was used when the heart rate was fast.

Second: targeted drug treatment of pulmonary hypertension (1) prostacyclins: they play an important role in the treatment of pulmonary hypertension, which can reduce pulmonary artery pressure and pulmonary vascular resistance, increase cardiac output and six minute walking distance, improve the quality of life and prolong the survival time. Commonly used are: iloprost (vantavir)（ 2) Endothelin receptor antagonist (ETA): endothelin (ET-1) is one of the important causes of pulmonary hypertension. Era can dilate pulmonary vessels, inhibit proliferation and improve endothelial function. Clinical application can improve activity tolerance and prolong survival time of patients. Bosentan is commonly used.

Third: PDE5: selectively inhibit PDE5 (a large number of expression in the lung), increase cGMP concentration in smooth muscle cells, relax vascular smooth muscle, expand pulmonary artery, reduce pulmonary vascular resistance, so as to reduce pulmonary artery pressure and increase activity tolerance. Commonly used are sildenafil (Viagra), vardenafil (Aida).

matters needing attention

Patients with pulmonary hypertension should properly adjust their daily activities, and avoid to high altitude areas, because hypoxic environment will aggravate pulmonary vasoconstriction in patients with pulmonary hypertension, making the disease worse.